Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies  Nima Rezaei, MD, PhD, Mona Hedayat, MD,

Slides:



Advertisements
Similar presentations
B-cell biology and development
Advertisements

Introduction to Receptors
Immune Receptors and Signal Transduction
Cellular Immune response
Monoclonal antibodies and fusion proteins in medicine
The Wnt signaling pathway in cancer
Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
Mario J. Grijalva, Ph.D. (pronounced gree-HALL-va)
Molecular regulation of mast cell activation
Histamine and H1-antihistamines: Celebrating a century of progress
Proximal signaling events in FcɛRI-mediated mast cell activation
Defects of class-switch recombination
Laurent L'homme, PhD, David Dombrowicz, PhD 
Advances in food allergy in 2015
You have identified a novel cytoplasmic protein
Miriam Marqués, Francisco X. Real  European Urology 
Therapy of autoinflammatory syndromes
The role of viruses in acute exacerbations of asthma
Primary Immunodeficiencies
Katherine R. Groschwitz, BS, Simon P. Hogan, PhD 
Signal Transduction Through the Epidermal Growth Factor Receptor
Signaling molecules as therapeutic targets in allergic diseases
Mechanisms of mast cell signaling in anaphylaxis
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer
Is 9 more than 2 also in allergic airway inflammation?
T-cell activation through the antigen receptor
Molecular regulation of mast cell activation
TNF-α–induced protein 3 (A20): The immunological rheostat
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Zuhair K. Ballas, MD  Journal of Allergy and Clinical Immunology 
Insights into primary immune deficiency from quantitative microscopy
Antimicrobial peptides and the skin immune defense system
T-cell activation through the antigen receptor
BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer
Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells
MicroRNAs: Essential players in the regulation of inflammation
Immune modulation by neuronal electric shock waves
Biologics and biomarkers for asthma, urticaria, and nasal polyposis
Role of IgE in autoimmunity
B-cell biology and development
Ricardo U. Sorensen, MD, Luke A. Wall, MD 
Charles E. Reed, MD, Hirohito Kita, MD 
Signal Transduction Through the Epidermal Growth Factor Receptor
Molecular mechanisms of IgE regulation
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
Signaling Takes Shape in the Immune System
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
Update on glucocorticoid action and resistance
Characterization of ζ-associated protein, 70 kd (ZAP70)–deficient human lymphocytes  Chaim M. Roifman, MD, Harjit Dadi, PhD, Raz Somech, MD, Amit Nahum,
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Platelet-derived growth factor (PDGF) signalling pathway.
Donald Y.M. Leung, MD, PhD  Journal of Allergy and Clinical Immunology 
T Cell Anergy: Where It's LAT
Eric N. Johnson, PhD, Kirk M. Druey, MD 
Primary immunodeficiencies: A rapidly evolving story
Chemokines and their receptors in allergic disease
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Targeting TNF-α: A novel therapeutic approach for asthma
The coreceptor programmed death 1 inhibits T-cell adhesion by regulating Rap1  Inbar Azoulay-Alfaguter, PhD, Marianne Strazza, PhD, Ariel Pedoeem, BS,
TH9 immunodeficiency in patients with hyper-IgE syndrome
Innate immune responses to infection
Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
Immune pathomechanism of drug hypersensitivity reactions
Advances and highlights in mechanisms of allergic disease in 2015
Natural history of cow’s milk allergy
Airway smooth muscle: A modulator of airway remodeling in asthma
Airway smooth muscle: An immunomodulatory cell
Itching as a systemic disease
Presentation transcript:

Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies  Nima Rezaei, MD, PhD, Mona Hedayat, MD, Asghar Aghamohammadi, MD, PhD, Kim E. Nichols, MD  Journal of Allergy and Clinical Immunology  Volume 127, Issue 6, Pages 1329-1341.e2 (June 2011) DOI: 10.1016/j.jaci.2011.02.047 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 SAP deficiency is associated with defective cellular and humoral immune responses in patients with XLP. A-C, SAP deficiency profoundly affects NK (Fig 1, A) and CD8+ T-cell (Fig 1, B) cytotoxicity and cytokine production and NKT cell development (Fig 1, C). Consequently, increased survival of EBV-infected B cells, together with impaired restimulation-induced cell death (RICD) of T cells, contributes to the development of FIM, malignant lymphoma, or both. D, SAP deficiency reduces T cell–dependent B-cell activation and immunoglobulin production. Journal of Allergy and Clinical Immunology 2011 127, 1329-1341.e2DOI: (10.1016/j.jaci.2011.02.047) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Contribution of the TEC family kinase ITK to TCR-mediated signaling pathways. ITK is required for full TCR-induced PLC-γ activation and Ca2+ mobilization, as well as Vav1 localization, signifying its role in TCR-induced signaling complex formation and stability. ITK deficiency alters actin cytoskeletal rearrangement, which probably results in reduced cellular cytotoxicity, as well as gene transcription (eg, decreased Fas ligand expression), which contribute to impaired activation-induced cell death. DAG, Diacylglycerol; ERK, extracellular signal-regulated kinase; IP3, inositol trisphosphate; LAT, linker for activation of T cells; MEK, mitogen-activated protein kinase kinase; NFAT, nuclear factor of activated T cells; RICD, restimulation-induced cell death; SOS, son of sevenless; ZAP-70, zeta-chain-associated protein kinase 70. Journal of Allergy and Clinical Immunology 2011 127, 1329-1341.e2DOI: (10.1016/j.jaci.2011.02.047) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Regulation of CXCR4 signaling. SDF-1 binding to CXCR4 initiates multiple intracellular signal transduction pathways and gene expression. Concomitant induction of GRK-mediated phosphorylation of the CXCR4 cytoplasmic tail results in β-arrestin–mediated receptor desensitization and endocytic internalization. In patients with WHIM syndrome, mutations in the cytoplasmic tail of CXCR4 disrupt receptor downregulation, resulting in prolonged receptor activation and enhanced chemotactic responsiveness to SDF-1. Journal of Allergy and Clinical Immunology 2011 127, 1329-1341.e2DOI: (10.1016/j.jaci.2011.02.047) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 DOCK8-mediated cytoskeletal rearrangement. Phosphatidylinositol (3,4,5)-triphosphate (PIP3) is produced downstream of multiple cell-surface receptors and assists in DOCK8 plasma membrane recruitment. Subsequently, DOCK8 binds to and activates the RhoGTPases CDC42 and RAC1, exchanging bound guanosine diphosphate (GDP) for free guanosine triphosphate (GTP), a key step in the regulation of actin cytoskeletal rearrangement, lamellipodia formation, and cell polarization, all of which are crucial for lymphocyte activation, proliferation, and effector function. PI3K, Phosphoinositide 3-kinase; RAC1, Ras-related C3 botulinum toxin substrate 1; ZAP-70, zeta-chain-associated protein kinase 70. Journal of Allergy and Clinical Immunology 2011 127, 1329-1341.e2DOI: (10.1016/j.jaci.2011.02.047) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions